APP and Alzheimer disease: In parallel studies conducted in female TAPP mice, an AD transgenic line expressing both APP and tau transgenes, ABT-239 infusion reversed tau hyperphosphorylation in the spinal cord and hippocampus (Bitner et al., 2011).